Brainreader

Brainreader develops Neuroreader, an FDA-cleared and CE-marked software tool that performs quantitative brain MRI analysis for clinicians and researchers. The system processes routine MRI scans to quantify 83 brain structures, generating objective volumetric data that highlights subtle atrophy patterns associated with neurodegenerative diseases such as Alzheimer's, mild cognitive impairment, traumatic brain injury, and epilepsy. Reports are delivered in under ten minutes to assist with diagnostic confidence and longitudinal tracking without requiring changes to existing clinical workflows.

The company's technology is built on peer-reviewed validation studies reporting high accuracy, and the software has been in clinical use since 2011. Hospitals, imaging centers, and neurology practices access the tool through a pay-per-use model that integrates with standard picture archiving and communication systems or web uploads.